Anomera Inc.
USPTO PatentsView assignee record - 5 granted patents across 13 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations).
The verdict
According to USPTO PatentsView, Anomera ranks #44,733 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 13 technology areas.
- #44,733
- of 49,997 US assignees by volume
- Top 47%
- by Innovation Score (36.2/100)
- 21.4
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R44733 · Foreign Corporation #44,733 · 5 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 5 grants
- LOWER-Q #44,733/49,997
- PHOTO-FINISH Angioclinic
- CPC-FOCUS A61Q · 13 areas
- INNOV-THIN 36.2/100
- CLAIMS-DENSE 21.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2020–2024 · 5y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Angioclinic AG (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Anomera’s 36.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Anomera
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Anomera · this assignee
Anomera · this assignee
36 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Anomera's Innovation Score is 36.2/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Anomera?
Each dot is one of Anomera’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Anomera’s own 21.4 claims/patent is ABOVE the 12.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Anomera's grants concentrate
Anomera Inc. is a focused PatentsView assignee: 13 CPC subclasses with 80% of grants classified under A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2020. By volume, Anomera sits between Angioclinic AG and Antares Vision S.p.A..
Anomera's three-year grant acceleration
Anomera Inc. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Anomera's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Angioclinic
Angioclinic AG
5 patents
- Anhui Maoxin Home…
Anhui Maoxin Home Crafts Co., Ltd.
5 patents
- Anixa Diagnostics
Anixa Diagnostics Corporation
5 patents
- Ankom Technology
Ankom Technology Corporation
5 patents
- Anovent Pharmaceu…
Anovent Pharmaceutical (U.S.), LLC
5 patents
- Anqing Medical
Anqing Medical Co., Ltd.
5 patents
- Ansaldo Energia S…
Ansaldo Energia S.P.A.
5 patents
- Antares Vision S…
Antares Vision S.p.A.
5 patents
- Anomera ◀
Anomera Inc.
5 patents
What this shows Anomera holds 5 patents at rank #44,559, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Anomera
By rank, the assignees closest to #44,559 in granted patent volume.
- Angioclinic AG #44,555 · 5 patents
- Anhui Maoxin Home Crafts Co., Ltd. #44,556 · 5 patents
- Anixa Diagnostics Corporation #44,557 · 5 patents
- Ankom Technology Corporation #44,558 · 5 patents
- Anovent Pharmaceutical (U.S.), LLC #44,560 · 5 patents
- Anqing Medical Co., Ltd. #44,561 · 5 patents
- Ansaldo Energia S.P.A. #44,562 · 5 patents
- Antares Vision S.p.A. #44,563 · 5 patents
Leaders in A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations)
Other assignees with the most granted patents in Anomera's primary technology class.
Anomera's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
36 Top 47% higher than 53% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 20.0% |
| 2021 | 2 | 40.0% |
| 2022 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
Which technologies does Anomera Inc. patent most?
Top 13 of 13 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Anomera Inc.'s patent record in context - here's where to go next.
- Anomera Inc.'s lead technology class is A61Q (Specific USE OF Cosmetics OR Similar Toiletry Preparations), 80% of its portfolio - see every assignee active in that class. Explore A61Q
- Ranked #44,733 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Anomera Inc. against Angioclinic AG, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 36.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.